Level Chart

Basic Info

Regeneron Pharmaceuticals (REGN) - Collabaration Revenue is at a current level of 1.660B, up from 1.524B last quarter and up from 1.438B one year ago. This is a change of 8.93% from last quarter and 15.42% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.660B
Latest Period Sep 2024
Last Updated Oct 31 2024, 09:23 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 32.54%
Value from Last Quarter 1.524B
Change from Last Quarter 8.93%
Value from 1 Year Ago 1.438B
Change from 1 Year Ago 15.42%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 1.660B
June 30, 2024 1.524B
March 31, 2024 1.267B
December 31, 2023 1.37B
September 30, 2023 1.438B
June 30, 2023 1.317B
March 31, 2023 1.378B
December 31, 2022 1.587B
September 30, 2022 1.051B
June 30, 2022 1.044B
Date Value
March 31, 2022 1.232B
December 31, 2021 890.30M
September 30, 2021 1.074B
June 30, 2021 954.70M
March 31, 2021 754.40M
December 31, 2020 677.70M
September 30, 2020 653.20M
June 30, 2020 513.30M
March 31, 2020 528.30M
December 31, 2019 481.60M

Basic Info

Regeneron Pharmaceuticals (REGN) - Collabaration Revenue is at a current level of 1.660B, up from 1.524B last quarter and up from 1.438B one year ago. This is a change of 8.93% from last quarter and 15.42% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.660B
Latest Period Sep 2024
Last Updated Oct 31 2024, 09:23 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 32.54%
Value from Last Quarter 1.524B
Change from Last Quarter 8.93%
Value from 1 Year Ago 1.438B
Change from 1 Year Ago 15.42%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
REGN Regeneron Pharmaceuticals Inc -3.43%